We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
+16.29%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$106M
AUM Growth
+$11.3M
(+12%)
Cap. Flow
+$4.1M
Cap. Flow
% of AUM
3.86%
Top 10 Holdings %
Top 10 Hldgs %
34.45%
Holding
105
New
5
Increased
22
Reduced
41
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MDxHealth
MDXH
|
+$1.48M |
| 2 |
BIOL
Biolase, Inc.
BIOL
|
+$1.3M |
| 3 |
AKTS
Akoustis Technologies Inc
AKTS
|
+$1.17M |
| 4 |
EMKR
Emcore Corp
EMKR
|
+$1.02M |
| 5 |
Tactile Systems Technology
TCMD
|
+$724K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Digi International
DGII
|
+$1.33M |
| 2 |
Achieve Life Sciences
ACHV
|
+$384K |
| 3 |
ASPU
ASPEN GROUP, INC.
ASPU
|
+$302K |
| 4 |
Perion Network
PERI
|
+$279K |
| 5 |
Quest Diagnostics
DGX
|
+$231K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 57.45% |
| 2 | Technology | 23.08% |
| 3 | Communication Services | 7.64% |
| 4 | Industrials | 5.85% |
| 5 | Consumer Staples | 3.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CTLP
26
DELISTED
Cantaloupe
CTLP
| $1.56M | 1.47% |
274,350
-1,000
| -0.4% | -$5.33K |
|
27
OptimizeRx
OPRX
$130M
| $1.49M | 1.4% |
101,863
+100
| +0.1% | +$1.67K |
|
|
28
Tactile Systems Technology
TCMD
$674M
| $1.38M | 1.3% |
84,234
+52,000
| +161% | +$724K |
|
29
AtriCure
ATRC
$1.97B
| $1.38M | 1.3% |
33,350
| – | – |
|
30
QuickLogic
QUIK
$252M
| $1.38M | 1.3% |
232,463
-5,072
| -2% | -$29K |
|
|
31
MDxHealth
MDXH
$22.6M
| $1.32M | 1.25% |
408,725
+323,920
| +382% | +$1.48M |
|
32
Merck
MRK
$318B
| $1.26M | 1.19% |
11,825
-100
| -0.8% | -$10.8K |
|
33
Target
TGT
$67.2B
| $1.24M | 1.17% |
7,475
| – | – |
|
34
Magnite
MGNI
$2.95B
| $1.24M | 1.16% |
133,325
-2,750
| -2% | -$29.3K |
|
35
Fortress Biotech
FBIO
$94M
| $1.16M | 1.1% |
94,601
+39,767
| +73% | +$474K |
|
36
Gilead Sciences
GILD
$162B
| $1.13M | 1.07% |
13,617
-200
| -1% | -$16.6K |
|
|
FPAY
37
DELISTED
FlexShopper
FPAY
| $1.1M | 1.04% |
1,296,960
+15,500
| +1% | +$15.9K |
|
38
Bristol-Myers Squibb
BMY
$130B
| $1.08M | 1.02% |
15,641
| – | – |
|
39
Vericel Corp
VCEL
$2.36B
| $993K | 0.94% |
33,867
-2,200
| -6% | -$63.8K |
|
|
EMKR
40
DELISTED
Emcore Corp
EMKR
| $961K | 0.91% |
+83,600
| New | +$1.02M |
|
41
Ciena
CIEN
$58.3B
| $945K | 0.89% |
18,000
| – | – |
|
|
42
Achieve Life Sciences
ACHV
$681M
| $933K | 0.88% |
137,212
-80,888
| -37% | -$384K |
|
|
PDCO
43
DELISTED
Patterson Companies, Inc.
PDCO
| $909K | 0.86% |
33,970
-1,800
| -5% | -$50.6K |
|
44
8x8 Inc
EGHT
$326M
| $882K | 0.83% |
211,500
+3,000
| +1% | +$15K |
|
45
Apple
AAPL
$4.52T
| $767K | 0.72% |
4,650
| – | – |
|
|
BIOL
46
DELISTED
Biolase, Inc.
BIOL
| $766K | 0.72% |
27,235
+26,773
| +5,795% | +$1.3M |
|
47
AT&T
T
$157B
| $752K | 0.71% |
39,042
-200
| -0.5% | -$3.82K |
|
48
Castle Biosciences
CSTL
$948M
| $707K | 0.67% |
31,110
| – | – |
|
49
BioLife Solutions
BLFS
$1.63B
| $696K | 0.66% |
32,000
| – | – |
|
50
Apyx Medical
APYX
$176M
| $647K | 0.61% |
224,800
+189,000
| +528% | +$552K |
|
Similar funds
PWP
BF
HWMG
FTEA
WT
BAM
WLG
PA
Perkins Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Perkins Capital Management held 105 positions worth $106M, up 12% from $94.7M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Perkins Capital Management deployed $4.1M of net new capital in Q1 2023, opening 5 new positions and adding to 22 existing holdings. Its largest new stake was Emcore Corp: 83,600 shares worth $961K.
By sector, the portfolio is most concentrated in Healthcare at 57% of assets, up from 57% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Digi International, an estimated $1.33M trimmed.
- Perkins Capital Management's largest Q1 2023 buy was Emcore Corp: 83,600 shares worth $961K.
- Perkins Capital Management added most to MDxHealth in Q1 2023, an estimated $1.48M increase.
- Perkins Capital Management's biggest Q1 2023 reduction was Digi International, cutting an estimated $1.33M.
- Perkins Capital Management fully exited ASPEN GROUP, INC. in Q1 2023, selling an estimated $302K.
- Perkins Capital Management's ten largest holdings make up 34% of its $106M portfolio in Q1 2023.
- Perkins Capital Management opened 5 new positions and closed 8 in Q1 2023.
- Perkins Capital Management's portfolio value rose 12% quarter-over-quarter to $106M.
Based on Perkins Capital Management's 13F filing for Q1 2023, filed 9 May 2023.